K-2c-I
βk-2C-I is a novel psychoactive substance whose nomenclature indicates it is the beta-keto analogue of 2C-I, a substituted phenethylamine psychedelic. Virtually no formal research or documentation exists regarding its pharmacology, subjective effects, toxicity, or safety profile. Due to the extreme scarcity of available data, this substance should be approached with significant caution, and thorough harm reduction practices are strongly encouraged for anyone who encounters it.
Contents
Dosage & Duration
Dosage
Subjective Effects
K-2C-I produces a stimulating psychedelic experience broadly in line with its parent compound 2C-I, combining euphoria, empathic warmth, and insight with brightened colors and visuals that appear with eyes both open and closed. Perception is noticeably altered and the sense of self may soften, though the state can also tip into confusion. Mental and physical stimulation run throughout the experience and can persist as difficulty sleeping afterward.
Physical
The body load is stimulating and somewhat restless, with decreased appetite, dilated pupils, muscle tension, alternating sweating and chills, and difficulty sleeping.
Stimulation
Cognitive
The headspace is euphoric and empathic, with a capacity for insight and a mild softening of ego boundaries; confusion can also occur.
Emotional
Visual
Visual effects include brightened colors alongside closed- and open-eye visuals.
Tactile
Reagent Testing
Loading reagent data
Pharmacology
Tolerance
Harm Potential
Psychosis Risk
The provided effects list includes psychedelic visuals, changes in perception, confusion, restlessness, and insomnia. Persistent psychosis is not established by the available reports.
History & Culture
Legality
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the K-2c-I article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.